This is underscored by a recent report on psychiatric adverse events associated with GLP-1 analogs, which found an increased odds ratio for eating disorders, binge eating, self-induced vomiting, and fear of eating among those using GLP-1 analogs (127). This evidence concerns the gene GCG and eating disorder.